NO20074679L - Adjuvanssammensetning omfattende aluminiumforfat og 3D-MPL - Google Patents
Adjuvanssammensetning omfattende aluminiumforfat og 3D-MPLInfo
- Publication number
- NO20074679L NO20074679L NO20074679A NO20074679A NO20074679L NO 20074679 L NO20074679 L NO 20074679L NO 20074679 A NO20074679 A NO 20074679A NO 20074679 A NO20074679 A NO 20074679A NO 20074679 L NO20074679 L NO 20074679L
- Authority
- NO
- Norway
- Prior art keywords
- adjuvant
- mpl
- adjuvant composition
- aluminum scaffold
- deasylated
- Prior art date
Links
- 239000002671 adjuvant Substances 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 4
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 title 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 229940035032 monophosphoryl lipid a Drugs 0.000 abstract 2
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
En immunogen sammensetning omfattende: (i) et antigen; (ii) en aluminiumfiosfiat adjuvans; og (iii) en 3-0-deasylert monofiosfioiyl lipid A adjuvans. Komponent (ii) og (iii) kan også bli anvendt som et atskilt adjuvanssystem. En rekke trekk ved sammensetningene er beskrevet, inkludert at minst 50% av 3-0-deasylert monofiosfioiyl lipid A adjuvans adsorberes til aluminiumfiosfiat adjuvansen. Adjuvansblandingen er spesielt anvendbar med hepatitt B overflate antigen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65374105P | 2005-02-16 | 2005-02-16 | |
PCT/GB2006/000557 WO2006087563A2 (en) | 2005-02-16 | 2006-02-16 | Adjuvant composition comprising aluminium phosphate and 3d-mpl |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20074679L true NO20074679L (no) | 2007-09-13 |
Family
ID=36916823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20074679A NO20074679L (no) | 2005-02-16 | 2007-09-13 | Adjuvanssammensetning omfattende aluminiumforfat og 3D-MPL |
Country Status (18)
Country | Link |
---|---|
US (1) | US20090214592A1 (no) |
EP (1) | EP1850871A2 (no) |
JP (1) | JP2008530195A (no) |
KR (1) | KR20070110513A (no) |
CN (1) | CN101146551A (no) |
AP (1) | AP2007004151A0 (no) |
AU (1) | AU2006215419B2 (no) |
BE (1) | BE1016991A6 (no) |
BR (1) | BRPI0608430A2 (no) |
CA (1) | CA2598079A1 (no) |
EA (1) | EA012212B1 (no) |
IL (1) | IL185346A0 (no) |
MX (1) | MX2007009961A (no) |
NO (1) | NO20074679L (no) |
NZ (1) | NZ560930A (no) |
SG (1) | SG160328A1 (no) |
WO (1) | WO2006087563A2 (no) |
ZA (1) | ZA200707089B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ565512A (en) * | 2005-08-02 | 2011-08-26 | Novartis Vaccines & Diagnostic | Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
EP1862176A1 (de) * | 2006-05-31 | 2007-12-05 | Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH | Ein Verfahren zur Herstellung einer Impfzusammensetzung |
EP1862177A1 (de) * | 2006-06-01 | 2007-12-05 | Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH | Ein Verfahren zur Herstellung einer Impfzusammensetzung |
EP2066344B2 (en) * | 2006-09-07 | 2016-06-29 | GlaxoSmithKline Biologicals S.A. | Inactivated Poliovirus combination vaccine |
US20120058149A1 (en) * | 2009-03-05 | 2012-03-08 | Mccloskey Jenny Colleen | Treatment of infection |
CN102526724B (zh) * | 2011-01-14 | 2015-07-22 | 四川大学 | 氢氧化铝凝胶-多糖复合免疫佐剂及其制备方法和用途 |
AU2012279154A1 (en) * | 2011-07-01 | 2014-02-20 | The Regents Of The University Of California | Herpes virus vaccine and methods of use |
CN103330936B (zh) * | 2013-07-18 | 2016-01-27 | 北京民海生物科技有限公司 | 一种磷酸铝佐剂原位法制备乙肝疫苗的方法 |
RU2016141621A (ru) * | 2014-03-25 | 2018-04-25 | Зэ Гавермент Оф Зэ Юнайтед Стэйтс Оф Америка Эс Репрезентед Бай Зэ Секретари Оф Зэ Арми | Способы усиления эффективности иммуностимуляции адсорбированных на соли алюминия вакцин |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4707542A (en) * | 1983-08-22 | 1987-11-17 | Merck & Co., Inc. | Immunogenic HbsAg derived from transformed yeast |
GB8508685D0 (en) * | 1985-04-03 | 1985-05-09 | Minor P D | Peptides |
US4912094B1 (en) * | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
US5084282A (en) * | 1990-08-16 | 1992-01-28 | J.C. Steele & Sons | Apparatus for forming bricks having a textured edge |
DE59100033D1 (de) * | 1991-04-26 | 1993-03-04 | Lingl Anlagenbau | Verfahren und vorrichtung zum kerben eines tonstrangstueckes. |
US6620414B2 (en) * | 1992-03-27 | 2003-09-16 | Smithkline Beecham Biologicals (S.A.) | Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A |
WO1994021292A1 (en) * | 1993-03-23 | 1994-09-29 | Smithkline Beecham Biologicals (S.A.) | Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
US6488934B1 (en) * | 1995-02-25 | 2002-12-03 | Smithkline Beecham Biologicals S.A. | Hepatitis B vaccine |
GB9503863D0 (en) * | 1995-02-25 | 1995-04-19 | Smithkline Beecham Biolog | Vaccine compositions |
US20010053365A1 (en) * | 1995-04-25 | 2001-12-20 | Smithkline Beecham Biologicals S.A. | Vaccines |
GB9718901D0 (en) * | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
EP2266604A3 (en) * | 1998-10-16 | 2011-05-11 | GlaxoSmithKline Biologicals S.A. | Adjuvant systems and vaccines |
GB9822714D0 (en) * | 1998-10-16 | 1998-12-09 | Smithkline Beecham Sa | Vaccines |
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
US7030094B2 (en) * | 2002-02-04 | 2006-04-18 | Corixa Corporation | Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 |
-
2006
- 2006-02-16 EP EP06709794A patent/EP1850871A2/en not_active Withdrawn
- 2006-02-16 JP JP2007555701A patent/JP2008530195A/ja active Pending
- 2006-02-16 KR KR1020077020557A patent/KR20070110513A/ko not_active Application Discontinuation
- 2006-02-16 US US11/884,610 patent/US20090214592A1/en not_active Abandoned
- 2006-02-16 CA CA002598079A patent/CA2598079A1/en not_active Abandoned
- 2006-02-16 BE BE2006/0093A patent/BE1016991A6/fr not_active IP Right Cessation
- 2006-02-16 BR BRPI0608430-3A patent/BRPI0608430A2/pt not_active IP Right Cessation
- 2006-02-16 AP AP2007004151A patent/AP2007004151A0/xx unknown
- 2006-02-16 SG SG201001026-2A patent/SG160328A1/en unknown
- 2006-02-16 AU AU2006215419A patent/AU2006215419B2/en not_active Ceased
- 2006-02-16 MX MX2007009961A patent/MX2007009961A/es not_active Application Discontinuation
- 2006-02-16 WO PCT/GB2006/000557 patent/WO2006087563A2/en active Application Filing
- 2006-02-16 NZ NZ560930A patent/NZ560930A/en not_active IP Right Cessation
- 2006-02-16 EA EA200701743A patent/EA012212B1/ru not_active IP Right Cessation
- 2006-02-16 CN CNA2006800090340A patent/CN101146551A/zh active Pending
-
2007
- 2007-08-16 IL IL185346A patent/IL185346A0/en unknown
- 2007-08-22 ZA ZA200707089A patent/ZA200707089B/xx unknown
- 2007-09-13 NO NO20074679A patent/NO20074679L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20090214592A1 (en) | 2009-08-27 |
AU2006215419B2 (en) | 2012-03-08 |
EP1850871A2 (en) | 2007-11-07 |
EA012212B1 (ru) | 2009-08-28 |
CN101146551A (zh) | 2008-03-19 |
WO2006087563A2 (en) | 2006-08-24 |
AU2006215419A1 (en) | 2006-08-24 |
ZA200707089B (en) | 2008-11-26 |
EA200701743A1 (ru) | 2008-02-28 |
WO2006087563A3 (en) | 2007-03-15 |
BRPI0608430A2 (pt) | 2009-12-29 |
AP2007004151A0 (en) | 2007-10-31 |
JP2008530195A (ja) | 2008-08-07 |
SG160328A1 (en) | 2010-04-29 |
BE1016991A6 (fr) | 2007-11-06 |
NZ560930A (en) | 2011-06-30 |
IL185346A0 (en) | 2008-02-09 |
KR20070110513A (ko) | 2007-11-19 |
CA2598079A1 (en) | 2006-08-24 |
MX2007009961A (es) | 2008-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20074679L (no) | Adjuvanssammensetning omfattende aluminiumforfat og 3D-MPL | |
MY150706A (en) | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant | |
DK1951299T3 (da) | Influenzavacciner indeholdende kombinationer af partikelformige adjuvanser og immunforstærkere | |
MY148464A (en) | Vaccine against varicella zoster virus | |
AR019026A1 (es) | Composicion adyuvante que comprende un surfactante, combinacion adyuvante que lo comprende, composicion de vacuna que los comprende, uso de dichosurfactante y dicha composicion para fabricar composicion de vacuna, dispositivo rociador relleno con dicha vacuna, uso de la composicion de vacuna, metodo | |
DE60045668D1 (de) | Influenzavirus-Impfstoffzusammensetzung | |
NZ592977A (en) | IgE CH3 PEPTIDE VACCINE | |
CU23759A3 (es) | Composiciones inmunogénicas | |
MX9302982A (es) | Composicion de vacuna que incluye componente de vacuna de la hepatitis b, para el tratamiento de infecciones por hepatitis b. | |
WO2006126981A3 (en) | Compositions and methods for mucosal vaccination | |
MX2010001054A (es) | Composiciones adyuvantes antigenicas y metodos. | |
BR0014285A (pt) | Adjuvantes compreendendo um éster ou éter de alquila de polioxietileno e pelo menos um tensoativo não-iÈnico | |
MX359517B (es) | Composiciones, formulaciones y metodos de compuestos lipidicos modificadores de respuestas inmunitaria. | |
CU23552A1 (es) | Composición vacunal | |
BRPI0507111A (pt) | processo para a preparação de um composto e seus adutos de mannich, composição, concentrado aditivo para combustìveis, e, usos de uma composição e de pelo menos um composto | |
BR0313876A (pt) | Uso de uma mistura, composições de combustìvel e de solvente, e, processo para a preparação de uma mistura | |
NO20091530L (no) | Fenylalkylaminokarbamat preparater | |
EA200801251A1 (ru) | Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма | |
MX9401225A (es) | Composicion de vacuna para prevenir la infeccion con influenza en humanos y metodo para su preparacion. | |
AR071741A1 (es) | Vacunas contra la malaria | |
CY1112149T1 (el) | Μειωση της παρεμβολης μεταξυ επικουρων που περιεχουν ελαιο και αντιγονων που περιεχουν τασιενεργο | |
NZ542328A (en) | Use of immune stimulating complex (ISCOM) particles as an adjuvant for an antigenic composition that comprises live micro organisms | |
AR054259A1 (es) | Vacuna contra virus de papiloma humano (hpv) | |
AR057555A1 (es) | Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo | |
WO2006030440A3 (en) | Use of tellurium compounds as adjuvants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |